Latest Publications

Our researchers publish numerous peer-reviewed articles and poster presentations each year across a variety of noteworthy journals. Take a look at our newest publications or search through historical publications by journal, date or therapeutic area.

Search
Cures

Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?

Cures

Authors: Adrian Towse, MA, MPhil, Elisabeth Fenwick, PhD

Payers are concerned that one-off “cures” bring great uncertainty with the consequential risk of incorrect adoption decisions, and significant budget impact from large one-off payments....

 Continue Reading
Deep vein thrombosis

Comparison of Quality Of Life Measurements: EQ-5D-5L versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis.

Deep vein thrombosis

Authors: LH Chuang, AT Cohen, G Agnelli, P Gumbs, R Bauersachs, S Kroep, AK Gitt, M Monreal, SN Willich, B van Hout

...

 Continue Reading
Peripheral Arterial Disease
HIV
chemotherapy

Cost-Effectiveness of a Fixed Combination of Netupitant and Palonosetron (NEPA) Relative to Aprepitant Plus Granisetron (APR + GRAN) for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV): A Trial-Based Analysis

chemotherapy

Authors: M Botteman, K Nickel, S Corman, M Turini, G Binder

Chemotherapy-induced nausea and vomiting (CINV) are among the most common and debilitating side effects patients experience during chemotherapy and are associated with considerable acute care use and healthcare cost....

 Continue Reading
infant
chemotherapy

Budget Impact of Netupitant/palonosetron for the Prevention of Chemotherapy-induced Nausea and Vomiting

chemotherapy

Authors: SH Park, G Binder, S Corman, M Botteman

Chemotherapy-induced nausea and vomiting (CINV) are among the most common and debilitating side effects patients experience during chemotherapy and are associated with considerable acute care use and healthcare cost....

 Continue Reading

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson’s Disease: Results from a pooled meta-analysis

Authors: David Standaert, Vardhaman Patel, Sonya Snedecor, Sandeep Thakkar, Yash J. Jalundhwala, Pavnit Kukreja, David Kratochvil, Yanjun Bao, Rajesh Pahwa

To evaluate short-term and long-term impact of carbidopa-levodopa enteral suspension (CLES) on quality of life (QoL) and activities of daily living (ADL) in patients with advanced Parkinson’s Disease (APD)....

 Continue Reading
Partner with Pharmerit

Partner with Pharmerit

Contact Us